Myriad Genetics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $1.18B
Liabilities Breakdown FY2018
Total Liabilities: $209.2M
Asset Breakdown
Total Assets: $1.18B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $110.9M | 9.4% |
| Accounts Receivable | $99.5M | 8.5% |
| Inventory | $34.3M | 2.9% |
| Property, Plant & Equipment | $43.2M | 3.7% |
| Goodwill | $318.6M | 27.1% |
| Intangible Assets | $455.2M | 38.7% |
| Other Assets | $113.6M | 9.7% |
Liabilities Breakdown
Total Liabilities: $209.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $26.0M | 12.4% |
| Long-Term Debt | $9.3M | 4.4% |
| Other Liabilities | $173.9M | 83.1% |